Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
University of Nebraska
Adela, Inc
Cancer Research UK
University of Alabama at Birmingham
Compugen Ltd
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Taproot Health
University of Modena and Reggio Emilia
Cedars-Sinai Medical Center
Novartis
Celgene
Celgene
University of Wisconsin, Madison
CureOne
Amgen
National Institutes of Health Clinical Center (CC)
Stanford University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Case Comprehensive Cancer Center